zoom_in Click to enlarge

Elizabeth Blackburn

▲ ▼

description Elizabeth Blackburn Overview

Elizabeth Blackburn is a pioneering Australian-American biologist renowned for her groundbreaking research on telomeres. Her work, alongside Carol Greider, revealed the function of telomerase, an enzyme vital to chromosome stability. This discovery significantly advanced our understanding of cellular aging and its connection to disease. Blackburn's research has been crucial for scientists investigating genetic mechanisms involved in human health and longevity, particularly those focusing on molecular biology and 21st-century advancements.

help Elizabeth Blackburn FAQ

What are telomeres and how did Elizabeth Blackburn's research change our understanding of them?

Telomeres are repetitive DNA sequences at the ends of chromosomes that protect genetic data from degradation during cell division. Elizabeth Blackburn's research, beginning with her work on the organism Tetrahymena in the 1970s and 1980s, revealed the structure and function of telomeres and led to the co-discovery of telomerase, the enzyme that rebuilds them.

When did Elizabeth Blackburn win the Nobel Prize?

Elizabeth Blackburn shared the Nobel Prize in Physiology or Medicine in 2009 with Carol Greider and Jack Szostak for their discoveries about how telomeres and the enzyme telomerase protect chromosomes. The research that earned the prize was primarily conducted in the 1980s and had far-reaching implications for understanding aging and cancer.

What is the connection between telomerase and cancer?

Most normal human cells gradually lose telomere length with each division, eventually stopping division altogether—a process linked to aging. Cancer cells, however, often reactivate telomerase to maintain their telomeres indefinitely, allowing them to divide without limit, which has made telomerase a major target for potential anti-cancer therapies.

Was Elizabeth Blackburn removed from the President's Council on Bioethics?

Yes, Elizabeth Blackburn was appointed to the President's Council on Bioethics by President George W. Bush in 2001 and was dismissed in 2004. Many in the scientific community believed her removal was politically motivated because her support for embryonic stem cell research clashed with the administration's positions.